Case Presentation A 36 year - old man with Fuchs' dystrophy underwent ... Immediately postoperatively, corneal graft displacement and peripheral corneal edema which remained stable during the ...

The fuchs endothelial corneal dystrophy market is expected to experience ... FECD is characterized by corneal edema, guttae formation, reduced visual acuity, and can ultimately lead to corneal ...

When cataract surgery leads to complications, patients arrive at the retina surgeon’s office scared and uncertain.As specialists, our role is not to dwell on how we got here but to chart the path ...

today announced that it will present an update on the progress of its DT-168 program for Fuchs endothelial corneal dystrophy (FECD) at Eyecelerator @ Park City 2025 on Friday, May 2, 2025 ...

The press release highlights that there are currently no available disease-modifying treatments for Fuchs endothelial corneal dystrophy, emphasizing the seriousness and lack of options for ...

In addition to its GeneTAC ® programs, DT-216P2, in development for patients with Friedreich ataxia, and DT-168, for Fuchs endothelial corneal dystrophy, the company is advancing programs in ...

today announced that it will present an update on the progress of its DT-168 program for Fuchs endothelial corneal dystrophy (FECD) at Eyecelerator @ Park City 2025 on Friday, May 2, 2025 ...

today announced that it will present an update on the progress of its DT-168 program for Fuchs endothelial corneal dystrophy (FECD) at Eyecelerator @ Park City 2025 on Friday, May 2, 2025, at 1:30 p.m ...